Monday 27 March 2017

NEJM Week of 23rd February 2017 (#83)

Professor Brian Andrews NEJM Recommendations for Medical Students and Tutors
Week of 23rd February 2017 (#83)
University of Notre Dame Australia (Fremantle Campus)



Occasional Editorial Comment


None


Must Read Articles


ORIGINAL ARTICLE

Assessing the Risks Associated with MRI in Patients with a Pacemaker or Defibrillator


A total of 1500 nonthoracic MRI examinations were performed on patients with a non–MRI-conditional pacemaker or ICD, after programming of the devices in accordance with a standardized protocol. No patient whose device was appropriately programmed had device or lead failure.

Over the past twenty years, pacemakers and implantable cardioverter-defibrillators (ICDs) have been designed to reduce the risks associated with MRI when used per defined protocol.

It is estimated that there are approximately eight million devices world-wide that are non-MRI-conditional or potentially not “MRI safe.” It is also estimated that approximately half of the patients with these devices will require an MRI in their lifetime.

1500 patients with non-MRI conditional devices were studied and received standard MRIs (77% for either the brain, cervical spine or lumbar spine). No MRIs were obtained of the thoracic cavity.  MRI machines with a magnetic field strength of 1.5 tesla were used.  Devices were programmed as per protocol before and after the MRI (MRIs were not performed on patients whose ICDs were pacing-dependent). During the study, there was no significant magnetic field-induced cardiac lead heating, although one patient experienced ICD failure, with the device needing to be replaced as protocol had not been followed with appropriate pre-MRI programming of the device. Otherwise no significant adverse events occurred. 



CLINICAL PRACTICE

Screening for Chlamydia trachomatis Infections in Women


Chlamydial infection may result in pelvic inflammatory disease, infertility, and ectopic pregnancy. Chlamydia screening is recommended in sexually active women younger than 25 years of age and other women at increased risk and can be performed on vaginal swabs or urine samples.

This is an excellent case-based review on chlamydial infections in women. The epidemiology, pathology and clinical presentations are defined followed by a discussion of screening strategies (see box insert for Key Clinical Points on screening). Treatment strategies and areas of uncertainty are outlined. This should be read by all medical students.

Recommended learning: Genital infections due to Chlamydia trachomatis.


IMAGES IN CLINICAL MEDICINE

Empyema Necessitatis


A 40-year-old man presented with fever, weight loss, dyspnea, and cough. Physical examination revealed a tender, bulging anterior thoracic mass.

This is an unusual complication of an empyema which, due to tuberculosis, tracks through the parietal pleura into the chest wall. There is an interesting clinical picture and CT scans.

Recommended learning: Review the pulmonary pathology of tuberculosis.



Articles Recommended for Medical Students



Perspective

Recreational Cannabis — Minimizing the Health Risks from Legalization


Twenty percent of the U.S. population now lives in states that have passed ballot initiatives to allow cannabis to be sold for recreational use. The net effect of cannabis legalization on public health is uncertain, and much will depend on how the laws are implemented.

This interesting Perspective summarises what is known and unknown regarding recreational cannabis use with respect to health effects, legalization, and public health policies. After reading this, I realized how much evidence based information needs to be gathered.




Important Articles Related to Mechanisms of Disease and Translational Research



None



Other Articles which should interest medical students



ORIGINAL ARTICLE

Tight Glycemic Control in Critically Ill Children


Tight glycemic control has not improved outcomes in studies involving critically ill adults or children after cardiac surgery. A controlled study involving hyperglycemic critically ill children who had not undergone cardiac surgery showed no benefit of tight glycemic control.

After this study involving tight glycaemic control in critically ill children (lower-target group at 4.4 – 6.1 mmol/L and higher-target group at 8.3 – 10.0 mmol/L), it now appears that in most studies to date on critically ill adults and children that clinical outcomes are not improved with tight glycaemic control.  As this study demonstrates, patients in the lower-target group (tight control) had more health care-associated infections and more episodes of severe hypoglycaemia.



IMAGES IN CLINICAL MEDICINE

Gastric Gyri — Pediatric Ménétrier’s Disease


A 5-year-old boy presented with nausea, vomiting, and intermittent abdominal pain. Images showed giant cerebriform enlargement of rugal folds in the fundus and the body, which were suggestive of Ménétrier’s disease.

When considering the gastrointestinal causes of hypoalbuminemia, one of the rarer causes, Menetrier’s disease, may need to be considered.

Recommended learning: Review the mechanisms, clinical entities associated with and approach to the management of hypoalbuminemia.


CASE RECORDS OF THE MASSACHUSETTS GENERAL HOSPITAL

Case 6-2017 — A 57-Year-Old Woman with Fatigue, Sweats, Weight Loss, Headache, and Skin Lesions


A 57-year-old woman presented with fatigue, night sweats, weight loss, headache, abdominal pain, and skin lesions. Laboratory testing revealed hypergammaglobulinemia and hypocomplementemia. Diagnostic tests were performed.
This CPC provides an excellent differential diagnosis of a patient presenting with fatigue, night sweats, weight loss, headache, abdominal pain, and skin lesions.  This patient is also found to have lacrimal gland enlargement, hypergammaglobulinemia, hypocomplementemia and increased plasma cells on a biopsy. I would not have even considered giant cell arteritis in my DD. The diagnosis is an IgG4-related disease, the group of which also includes disorders such as autoimmune pancreatitis and idiopathic retroperitoneal fibrosis.
IgG4 related disorders have been previously discussed in issues # 64, http://www.nejm.org/doi/full/10.1056/NEJMcpc1610097  and #14 http://www.nejm.org/doi/full/10.1056/NEJMra1104650.


New and Novel Therapies



ORIGINAL ARTICLE

Inhibiting Plasma Kallikrein for Hereditary Angioedema Prophylaxis


In patients with hereditary angioedema with C1 inhibitor deficiency, swelling episodes are related to the release of bradykinin from high-molecular-weight kininogen from kallikrein action. Lanadelumab, which inhibits kallikrein action, reduced the rate of attacks of angioedema.

EDITORIAL

Kallikrein Inhibition for Hereditary Angioedema


Hereditary angioedema (HA), due to a functional deficiency in C1 (esterase) inhibitor (types I and II), is a rare disorder and is usually autosomal dominant in inheritance.  Deficient function of C1INH results in ongoing activation of the classical complement system with reduced C4 levels, activation of the coagulation system and activation of the kallikrein-kinin system (Fletcher factor deficiency is a rare congenital absence of prekallikrein which does not produce any significant clinical manifestations). Kallikrein generation from prekallikrein leads to excessive proteolysis of high MW kininogen and formation of bradykinin which results in vasodilation, vascular leakage, oedema and pain.  80% of patients with HA exhibit reduced production of C1INH, while 20% have functional inhibition of C1INH usually due to autoantibodies (SLE and B cell lymphomas).

The clinical manifestations of HA result from intermittent subcutaneous oedema of the hands, feet, face and abdominal wall and from submucosal oedema of the mouth, airways, GIT and genitourinary system.  There is no urticaria or pruritus associated with this condition. Patients usually present with recurrent painful swelling of lips, tongue, and airways compromising breathing and abdominal pain.

This study employs the prophylactic use of a monoclonal antibody (lanadelumab) against kallikrein, resulting in reduced cleavage of high MW kininogen and reduced plasma levels of bradykinin, which leads to fewer episodes of clinical angioedema.

The prophylactic use of this monoclonal antibody was effective and produced no significant adverse events in this brief six week, phase 1b study.  This is really an “appetiser study” responsible in part for some of the literature pollution that occurs. If this study had not been performed at the MGH in Boston, it would not have been published in the Journal. As the authors indicate in their discussion, the full phase 3 six-month (24 week) study is under way and had undoubtedly been completed at the time of submission and subsequent publication of this study. Maybe the results of another agent for treating HA are soon to be published in the Journal.



Articles Some Medical Students Found Interesting




Perspective

HISTORY OF MEDICINE

The Death of Animals in Medical School

Although live animals had been used in medical education for millennia, with recent changes at Johns Hopkins and the University of Tennessee, every core U.S. medical school curriculum has now ceased this practice. It is worth considering the causes and implications of this milestone.

This is an interesting historical review of the use of live animals in medical education in the US.


ORIGINAL ARTICLE

Genetic Drivers of Kidney Defects in the DiGeorge Syndrome


A third of patients with the DiGeorge syndrome have congenital kidney and urinary tract anomalies. This study provides evidence that haploinsufficiency of CRKL is associated with such anomalies in the DiGeorge syndrome and in sporadic congenital kidney and urinary tract anomalies.

I found this to be a fascinating study, though none of the medical students in my groups felt the same, until we discussed the article in some detail.

This is a truly an extensive and elegant study involving 2080 patients with congenital kidney and urinary tract abnormalities and 22,094 controls. The authors performed a genome wide search for structural variants in 22q11.2 in the above two cohorts.

This article illustrates the following:

1.     30% of patients with DiGeorge syndrome have congenital renal and urinary tract abnormalities.  They also exhibit the more well-characterized thymic aplasia with profound T cell immunodeficiency, hypoparathyroidism leading to hypocalcaemia, congenital cardiac malformations frequently requiring early surgery and facial and neck abnormalities.

2.     Most non-renal manifestations of the DiGeorge syndrome are associated with small deletions in chromosome 22, resulting in loss of function in TBX1 (the tbx1 gene translates the T-box 1 protein).

3.     The T-box 1 protein appears to be necessary for the normal development of large arteries that carry blood out of the heartmuscles and bones of the face and neck, and glands such as the thymus and parathyroid (Wikipedia).

4.     The hypothesis was generated that if renal abnormalities in DiGeorge syndrome were not attributable to deletions involving the tbx1 gene on 22q11.2, could another deletion in a nearby area of 22q11.2 on chromosome 22 be responsible?

5.     The authors identified a heterozygous 370 kB deletion in 22q11.2 containing a series of nine genes that when absent were associated with the renal defects in the DiGeorge syndrome. Further characterization of these genes identified the three important responsible genes, snap29, aifm3 and crkl.  However, absence of the crkl gene alone resulted in renal agenesis or hypodysplasia.

6.     CRKL encodes an adapter protein that regulates intracellular signalling transduction from multiple growth factors, including the fibroblast growth factors, which are key regulators of kidney and urinary tract development (article).

7.     In zebra fish embryos, the authors produced a crkl loss of function mutation which resulted in renal defects. In a mouse model, inactivation of crkl resulted in similar renal abnormalities to those in humans.

8.     In 1.1% of the 2080 humans with congenital renal abnormalities and in 0.01% of the population controls, heterozygous deletions of 22q11.2 were identified.

9.     The authors have identified a gene crkl that is responsible for the congenital renal abnormalities of the DiGeorge syndrome and a small number of patients with sporadic congenital renal and urinary tract abnormalities.   

Tuesday 21 March 2017

NEJM Week of 16th February 2017 (# 82)

Professor Brian Andrews NEJM Recommendations for Medical Students and Tutors
Week of 16th February 2017 (#82)
University of Notre Dame Australia (Fremantle Campus)



Occasional Editorial Comment


None


Must Read Articles



ORIGINAL ARTICLE

Bariatric Surgery versus Intensive Medical Therapy for Diabetes — 5-Year Outcomes


Five-year data showed that among patients with type 2 diabetes and a BMI of 27 to 43, bariatric surgery plus intensive medical therapy was more effective than intensive medical therapy alone in decreasing or resolving hyperglycemia, even among those with a BMI of less than 35.

This is an important study that compares the results of intensive medical therapy (IMT) alone versus IMT plus bariatric surgery.  In the study, an equal number of patients had a sleeve gastrectomy or gastric bypass/Roux-en-Y. In Australia, most surgeries are now sleeve gastrectomies, or the correction of complications from earlier gastric banding.

Overall the results at five years demonstrate that IMT + surgery is clearly superior to IMT in all parameters (see Table 1, Figure 1). It should be noted that the study was conducted at three pre-eminent institutions (Harvard, the Cleveland Clinic, and Baylor) where “optimal’ IMT is the type of medical therapy one could only strive to attain in most sites in the US or Australia where diabetes is managed. In other words, optimal IMT is very difficult to achieve in other sites, probably making the results seen with bariatric surgery more significant.  In the 87 patients who had bariatric surgery it was remarkable that only one patient during the study had significant complications requiring revision surgery.  Adverse events are documented in Table 2. The long-term data on renal and ophthalmological complications is awaited.



Articles Recommended for Medical Students



Perspective

Addressing the Fentanyl Threat to Public Health


Governments can address widespread fentanyl-related deaths by pursuing a harm-reduction approach involving increased transparency for users and public health and public safety organizations, harm-reduction policing, expanded naloxone use, and targeted treatment.

This Perspective outlines the public health and medical complications following the introduction of fentanyl as an additive to heroine or non-prescribed morphine. Fentanyl, a potent synthetic opioid, is relatively easy and cheap to produce.  Fentanyl has been involved in 41% of deaths from morphine overdose in the US from 2012 through 2014.  In these situations, naloxone needs to be administered earlier and at escalated doses in patients where both fentanyl and morphine are combined, rather than with morphine alone. This will become an increasing problem in Australia as fentanyl is added to street morphine or heroine.



SPECIAL ARTICLE

Opioid-Prescribing Patterns of Emergency Physicians and Risk of Long-Term Use


In this analysis involving Medicare patients seen in emergency departments, rates of opioid prescribing varied widely among emergency physicians. Patients seen by physicians who prescribed opioids more frequently were more likely to use opioids on a long-term basis.

This is a study which attempts to quantify the risks of long-term use of opioids (180 days or more) in patients presenting to the ED in pain and who receive opioids for relief of the pain.  Patients, who have not received opioids within previous six months and who received treatment within the same hospital from high-intensity opioid prescribers were more likely to be taking opioids at six months than if they had initially visited a low-intensity opioid prescriber. This is a complex, well controlled and difficult study to undertake and must be read carefully.  Rates of opioid prescribing appear to vary by a factor of three within the same hospital. The population studied is an older Medicare population in the US, thus rates of long-term opioid use following a single ED visit for pain may differ from a younger population who do not have the comorbid diseases seen in the older population (Table 1).  



IMAGES IN CLINICAL MEDICINE

Gas in the Left Atrium and Ventricle


A 60-year-old man with clinically significant coexisting cardiac conditions presented with chest pain. Shortly after his initial admission, he suddenly collapsed. Scans showed air in his left ventricle.

The moral of the story is to pick a cardiologist who does the most procedures with the lowest frequency of adverse events.



Important Articles Related to Mechanisms of Disease and Translational Research


None


Other Articles which should interest medical students



ORIGINAL ARTICLE

Survival and Neurodevelopmental Outcomes among Periviable Infants


This study assessed survival and neurodevelopmental outcomes among infants born at 22 to 24 weeks of gestation, as measured at 18 to 22 months of corrected age, and showed that the rate of survival without neurodevelopmental impairment increased between 2000 and 2011.

EDITORIAL

Neonatal Intensive Care — The Only Constant Is Change

This is a study that addresses mortality and neurodevelopmental outcomes at 18 – 22 months (corrected age) in infants born between 22 - 24 weeks of gestation in three time periods (2000-2003, period 1; 2004 – 2007, period 2; and 2008 – 2011, period 3). It was conducted at 11 centres in the US and was NIH funded.

In infants born at 22 weeks in whom no active treatment was provided (76 -79% over the three periods), there was no change in the death rates (95-98%) or in the number of surviving infants with or without neurocognitive defects (NCDs) over the three periods (Table 2).

In infants born at 23 weeks, in whom active treatment was provided in 70 – 73%, the death rate did not change significantly (76% in period 3 and 80% in periods 1 and 2), although the number of infants surviving without NCDs increased from 7% in period 1 to 13% in period 3 (p = 0.005).

However, in infants born at 24 weeks in whom active treatment was provided (94 – 96%), the death rate fell from 51% to 44% (p <0.001) and the number of infants surviving without NCDs rose from 28 to 32% (p = 0.007) without any significant change in the percentage of infants born with NCDs over the three time periods. Thus, the improvement in mortality was not associated with an increased percentage of infants born with NCDs.
The study is analysed in the accompanying Editorial. Advances have occurred with improvements in perinatal and neonatal care. The limitations of the study are discussed, as are comparative studies in other countries together with the philosophy of care provided at these gestational ages.


ORIGINAL ARTICLE

Baricitinib versus Placebo or Adalimumab in Rheumatoid Arthritis


In a phase 3 randomized trial of 1307 patients with rheumatoid arthritis receiving background methotrexate, the oral JAK1 and JAK2 inhibitor baricitinib showed superior efficacy to placebo and to the anti–tumor necrosis factor α monoclonal antibody adalimumab.

 Since the introduction of the biological agent etanercept (Enbrel) by Wyeth, rheumatologists have learned how to use methotrexate successfully in rheumatoid arthritis.  Prior to this study, rheumatologists were afraid to use the current therapeutic doses of methotrexate, unlike our oncology colleagues, because of fears of producing bone marrow failure or cirrhosis.  The Wyeth funded study compared Enbrel directly with methotrexate, using an initial mean methotrexate dose of 17.5 mg/week.  Rheumatologists were stunned by the effectiveness of methotrexate, as well as the absence of any significant adverse effects. Wyeth was also stunned by the 12-month data which showed that methotrexate in these doses was as effective at treating RA as their new agent Enbrel. However, there is a happy ending for Wyeth, in that the 2-year data showed that Enbrel fared statistically better than methotrexate alone in treating active RA. This has been the most important study of therapeutics in RA (funded would you believe by a pharmaceutical company), in that it taught rheumatologists how to use methotrexate and introduced the first biological agent in the treatment of RA. We have come a long way since then in treating RA.

The current study introduces the new oral agent baricitinib, an inhibitor of the intracellular Janus kinases, JAK1 and JAK2.  Patients in this 52-week study (1307 patients, phase 3, double-blinded, placebo- and active-controlled trial of moderate to severe active RA who had failed to respond to methotrexate) were maintained on methotrexate (placebo) while other groups were treated with methotrexate together with either adalimumab (a monoclonal antibody against TNFa, standard therapy) or the study drug, baricitinib.

All data points studied, including radiological progression, over the 52-week study (see Figure 1) showed that baricitinib + methotrexate statistically outperformed adalimumab + methotrexate.  The withdrawal rate was slightly greater with baricitinib than adalimumab and adalimumab produced a greater increase in haemoglobin level than baricitinib (Table 2).


Recommended learning: Review the basic groups of drugs used to treat rheumatoid arthritis.                                                                             


CASE RECORDS OF THE MASSACHUSETTS GENERAL HOSPITAL

Case 5-2017 — A 19-Year-Old Man with Hematuria and a Retroperitoneal Mass


A 19-year-old man presented with a 2-day history of hematuria, without pain, after hiking. Imaging revealed a well-circumscribed 4.6-cm retroperitoneal mass. A procedure was performed.

This CPC involves the differential diagnosis of a South American patient presenting with painless haematuria.  He was found to have a mass which was anterior and medial to the right psoas muscle, anterior to the right common femoral artery and which produced mild medial deviation of the ureter. In the discussion, the cause of the haematuria was attributed to either vigorous exercise or the close proximity of the mass to the ureter (I do not really understand the pathology unless there was invasion of the thick muscular wall of the ureter). Why did the patient not also have a cystoscopy or tuberculin skin test/interferon g release assay and culture/PCR of urine for TB?



New and Novel Therapies



ORIGINAL ARTICLE

Osimertinib or Platinum–Pemetrexed in EGFR T790M–Positive Lung Cancer

In a randomized trial involving patients with non–small-cell lung cancer with mutant EGFR (T790M) in whom a tyrosine kinase inhibitor had failed, osimertinib was associated with significantly longer progression-free survival than platinum therapy plus pemetrexed.

Patients with advanced non-small cell lung cancer and sensitizing mutations of the epidermal growth factor receptor generally respond well to first -line EGFR tyrosine kinase inhibitors.  After 9 – 13 months, the majority recur with 60% developing a new EGFR resistance mutation inhibiting optimal binding of the first-line EGFR inhibitor. Osimertinib binds to both the sensitising and resistance EGFR mutations, again inhibiting down-stream signalling.

When osimertinib was compared with platinum + pemetrexed (folic acid antimetabolite inhibiting both purine and pyrimidine synthesis) in patients with advanced disease with both mutations, the former therapy improved disease-free survival over the latter group (10.1 months vs 4.4 months) as well as in the objective response rate (71% vs 31%).  In 144 patients with CNS metastases, progression-free survival was also increased with osimertinib (8.5 months vs 4.2 months). Grade 3 or higher adverse effects were lower in the osimertinib group than in the platinum + pemetrexed group (23% vs 47%).




Articles Some Medical Students Found Interesting



IMAGES IN CLINICAL MEDICINE

Eosinophilic Otitis Media


A 50-year-old man presented with a 6-month history of pain, otorrhea, and progressive hearing loss in both ears. Polypoid masses were found in both external ear canals.


This is an interesting case of otitis media.

Monday 6 March 2017

NEJM Week of 9th February 2017 (#81)

Professor Brian Andrews NEJM Recommendations for Medical Students and Tutors
Week of 9th February 2017 (#81)
University of Notre Dame Australia (Fremantle Campus)



Occasional Editorial Comment



None



Must Read Articles



REVIEW ARTICLE

Approach to Fever in the Returning Traveler


Travelers may be exposed to a variety of infectious agents that are endemic in the regions they visit. This review presents a systematic approach to the diagnosis and treatment of travel-acquired illnesses.

This is a must save article which students and interns will be using for years to come.

The article provides a clinical approach to the returning febrile traveller with fever and also includes an excellent Figure and Tables. At first sight, the Figure 1 algorithm appears daunting but is  a fount of information including clinical presentations and even antibiotic treatment for patients with fever. It should be carefully studied.

The simple Quick Sepsis-related Organ Failure Assessment tool (qSOFA) is described under the section Recognizing Life-Threatening Causes of Fever.

Table 2 describes the history that should be taken (covered in MEDI6300 clinical cases) from a returning traveller with fever. Table 1 contains a list of life-threatening tropical infections, and Table 3 a list of serious transmissible infections.



Articles Recommended for Medical Students



SPECIAL REPORT

Middle East Respiratory Syndrome


The Middle East respiratory syndrome is caused by a coronavirus that was first identified in Saudi Arabia in 2012. Periodic outbreaks continue to occur in the Middle East and elsewhere. This report provides the latest information on MERS.

The Middle East Respiratory Syndrome (MERS), while uncommon worldwide, is another viral cause (coronavirus) of an acute respiratory distress syndrome presenting with shortness of breath, fever, and lung infiltrates. This Special Report provides a state of the art summary on MERS.  The history of  both exposure to camels on the Arabian Peninsula (specifically camel saliva) and acquisition from an infected human contact is important when considering this diagnosis.

Figure 3 outlines the clinical presentation, modes of transmission, and the immunopathology of the lung infection. MEDI6100 have just had a lecture on acute inflammation and should find the diagram informative while providing some relevance to the topic. Students who have recently studied the pharmacological approach to type II diabetes mellitus will recall the gliptins and the incretin mimetics. In MERS, the surface receptor on bronchial epithelial cells and pneumocytes for MERS viral attachment is the receptor that binds DPP4 (dipeptidyl peptidase 4). Gliptins inhibit the enzyme DPP4 which degrades the incretins.  Incretins are necessary as glucagon mimics and for reducing gastric emptying, both leading to reductions in blood sugar levels.


IMAGES IN CLINICAL MEDICINE

Disseminated Blastomycosis


A 39-year-old man presented with acute hemoptysis, chills, and a traumatized left finger. Despite treatment with antibiotics, a repeat imaging study performed 8 weeks later showed a persistent pulmonary infiltrate.

The three common fungal infections in the US, Mexico and extending into central America, are coccidioidomycosis (West Coast and desert areas - “valley fever’ or “cocci”), histoplasmosis (follows the Mississippi river and its tributaries), and, as in this case, blastomycosis (East Coast and upper mid-West). This fungi enter primarily via the respiratory tract producing lung infiltrates and, in the case of blastomycosis, a predilection for the upper lube and occasional cavitation.



ORIGINAL ARTICLE

Thromboprophylaxis after Knee Arthroscopy and Lower-Leg Casting


Two trials, one involving patients undergoing knee arthroscopy and one involving patients with lower-leg casting, evaluated low-molecular-weight heparin as clot prophylaxis. The incidence of symptomatic venous thromboembolism was low, and anticoagulation did not influence it.


EDITORIAL

After the Fall — Prophylaxis for All?



CLINICAL DECISIONS

Thromboprophylaxis after Knee Arthroscopy


This interactive feature on thromboprophylaxis after knee arthroscopy offers a case vignette accompanied by essays that support either recommending or not recommending thromboprophylaxis. Vote and comment at NEJM.org.

The data from the article indicates that overall use of subcutaneous prophylactic injections of low MW heparin does not change the low frequency of symptomatic venous thromboembolism in patients undergoing knee arthroscopy or patients with lower extremity casts.

The Editorial provides the specifics of the study and an unbiased analysis of the results.

The Clinical Decisions article describes a patient undergoing an arthroscopic meniscectomy and discusses in point-counterpoint format the use of postoperative thromboprophylaxis. The bottom line is that the decision is usually made by the treating physician in conjunction with the orthopaedic surgeon based on the individual risk factors for the patient.  While the results of the study provide general guidelines, each patient and their potential risk factors should be considered individually.



Important Articles Related to Mechanisms of Disease and Translational Research



None



Other Articles which should interest medical students



CORRESPONDENCE

Acute Pancreatitis


This is interesting correspondence on pancreatic cancer as a trigger for acute pancreatitis, the possible role of incretin mimetics in pancreatitis, fine needle aspiration for culture of necrotic pancreas to determine antibiotic therapy, and clinical scoring systems for the severity of acute pancreatitis. There is also a good discussion of these areas by the author.



CASE RECORDS OF THE MASSACHUSETTS GENERAL HOSPITAL

Case 4-2017 — A 2-Month-Old Girl with Growth Retardation and Respiratory Failure


A 2-month-old girl presented with respiratory failure and growth retardation. Imaging revealed periventricular heterotopia (which her mother and grandmother also had), architectural distortion of the lungs, and cardiac abnormalities. Diagnostic procedures were performed.

This CPC involves a 2-month old girl with multiple defects, including periventricular heterotopia (I had never heard of this before).

I draw the reader’s attention to an extremely valuable web site OMIN (Online Mendelian Inheritance in Man (http://www.ncbi.nlm.nih.gov/omim ) which is an extensive database (pathology, epidemiology, specific genetics, and treatment) of all diseases, rare and common.  This site had its genesis in the massive classical work on Heritable Diseases by Victor McKusick (Johns Hopkins).

In 2001, we published a letter in the Ann Intern Med (Mouradi, B. and Andrews, B.S. Usefulness of Online Mendelian Inheritance in Man in Clinical Practice. Ann. Intern. Med.135:70, 2001). This publication involved a patient who had multiple seemingly disparate pathological conditions. By consulting OMIN, we were able to determine that all of these disorders were linked to a small region on a specific chromosome defining a new disease entity.

When the search terms periventricular heterotopia and congenital heart disease are entered, the correct diagnosis is found together with all you ever wanted to know about previous unusual clinical presentations and associated gene defects.


Perspective

Powerful Ideas for Global Access to Medicines


The UN High-Level Panel on Access to Medicines has reframed the access challenge not only as involving prices in lower-income countries, but also as requiring systemic changes to the prevailing research-and-development business model for the sake of all countries.



New and Novel Therapies



None



Articles Some Medical Students Found Interesting



ORIGINAL ARTICLE

Prognostic Mutations in Myelodysplastic Syndrome after Stem-Cell Transplantation


Prognostic systems for myelodysplasia rely on clinical factors, but particular genetic lesions can influence relapse rate, overall survival, and nonrelapse-related mortality as well as the choice of conditioning regimen for hematopoietic stem-cell transplantation.

This study further  illustrates the utility of determining specific genetic mutations, in this case in patients with the myelodysplastic syndrome (MDS) prior to receiving an allogeneic haematopoietic stem-cell transplantation.  Mutations in TP53, the RAS pathway, and JAK2 were able to help predict the responses to allogeneic haematopoietic stem-cell transplantation as well as which groups would benefit from myeloablative conditioning regimens rather than reduced-intensity conditioning regimens.


                 
IMAGES IN CLINICAL MEDICINE

Persistent Pupillary Membrane


A 15-year-old boy presented with diminution of vision in both eyes. Slit-lamp examination revealed persistent pupillary membranes caused by the presence of remnants of the blood supply to the fetal lens.